The pathogenic role of gadolinium in triggering nephrogenic systemic fibrosis in patients with renal disease has now been convincingly demonstrated, leading to preventive guidelines. Current Opinion in Rheumatology
Erica Frank, MD, MPH, President, Physicians for Social Responsibility; Professor and Chair, University of British Columbia, tells doctors why their preaching should match their practicing. Medscape General Medicine
A 10-year follow-up study confirms the effectiveness of cyclophosphamide followed by azathioprine (AZA) for treating proliferative lupus nephritis. Reuters Health Information
Rheumatoid arthritis therapy with the tumor necrosis factor (TNF)-alpha blocker infliximab leads to a reduction in measures of vascular stiffness, UK and Australian researchers report in the August issue of the Annals of the Rheumatic Diseases. Reuters Health Information
